Skip to main content
OpenTrials
Completed

NCT Number: NCT02262611

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Study to obtain long-term data on effects, safety and tolerability in routine medical practice and to investigate the potential of telmisartan to prevent secondary organ damage

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients of both gender aged >=18 admitted to a hospital due to insufficiently controlled essential hypertension.

No additional selection criteria have to be considered. Treatment was at the discretion of the physician following the summary of product information for Micardis® and MicardisPlus®

Exclusion criteria

  • not applicable

Treatment and study plan

Micardis®

Drug

MicardisPlus®

Drug

Primary outcomes

  1. Number of patients with adverse events

    Time frame: up to 1 year

  2. Number of patients with abnormal changes in laboratory parameters

    Time frame: up to 1 year

  3. Number of patients with clinically significant changes in vital signs

    Time frame: up to 1 year

  4. Change in systolic blood pressure

    Time frame: up to 1 year

  5. Change in diastolic blood pressure

    Time frame: up to 1 year

Secondary outcomes

  1. Global assessment of efficacy by investigator on a 4-point scale

    Time frame: 2 weeks, after 1 year

  2. Global assessment of tolerability by investigator on a 4-point scale

    Time frame: 2 weeks, after 1 year

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Important dates

Study start
2003
Primary completion
2005
First posted
Oct 13, 2014
Registry last updated
Oct 13, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.